INNOVATE BIOPHARMACEUTICALS, INC. (40) | Business Finance (17)

Browse by Subcategory

Recent Contracts

Underwriting Agreement, dated March 30, 2021, by and between 9 Meters Biopharma, Inc., Citigroup Global Markets Inc., William Blair & Company, L.L.C., and Truist Securities, Inc (Filed With SEC on April 5, 2021)
Registration Rights Agreement, dated April 29, 2020, between Innovate Biopharmaceuticals, Inc. and the investors named therein (Filed With SEC on May 4, 2020)
Securities Purchase Agreement, dated April 29, 2020, between Innovate Biopharmaceuticals, Inc. and the investors named therein (Filed With SEC on May 4, 2020)
Form of Series A Convertible Preferred Stock Warrant (Filed With SEC on May 4, 2020)
Note Purchase Agreement, dated January 10, 2020, by and between the Company and Atlas Sciences, LLC (Filed With SEC on January 10, 2020)
Form of Exchange Agreement (Filed With SEC on December 20, 2019)
Underwriting Agreement, dated December 11, 2020, by and between 9 Meters Biopharma, Inc., William Blair & Company, L.L.C., and Truist Securities, Inc., as representatives of the... (Filed With SEC on December 15, 2020)
Form of Amendment to Short-term Common Stock Purchase Warrant, dated February 6, 2020 (Filed With SEC on February 12, 2020)
Note issued to Atlas Sciences, LLC (Filed With SEC on January 10, 2020)
Form of Securities Purchase Agreement, dated April 29, 2019, by and among the Company and the purchasers party thereto (Filed With SEC on May 1, 2019)
Form of Placement Agent Warrant (Filed With SEC on May 1, 2019)
Form of Warrant (Filed With SEC on May 1, 2019)
Amendment, dated April 25, 2019, to Securities Purchase Agreement, dated as of March 17, 2019, by and between the Company and the Purchasers party thereto (Filed With SEC on April 26, 2019)
Form of Long-Term Warrant (included in Exhibit 10.1) (Filed With SEC on March 18, 2019)
Note issued to Atlas Sciences, LLC (Filed With SEC on March 13, 2019)
Note Purchase Agreement, dated March 8, 2019, by and between the Company and Atlas Sciences, LLC (Filed With SEC on March 13, 2019)
Option to Purchase Senior Convertible Note, by and between the Company and Gustavia Capital Partners LLC and/or its affiliates dated as of January 7, 2019 (Filed With SEC on January 11, 2019)